🟢 20/20 Biolabs is trading 10.64% up today amid broad market gains

20/20 Biolabs is trading at $0.60 (+10.64%) amid broad market strength after rebounding from the September 10 close of $0.54.

• Major U.S. indexes are rising more than 0.5%, supporting risk appetite.
• No fresh company-specific announcement explaining the September 11 move was identified; recent coverage concerns the September 2 investor webinar.
• The rebound follows several consecutive lower closes.